Encompass Health reports 2Q, ups full-year 2018 guidance

Encompass Health Corp. (NYSE: EHC), a national leader in post-acute care, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies, today reported its results of operations for the second quarter ended June 30, 2018.

“The second quarter was another strong quarter for Encompass Health with solid operating and financial results in both business segments,” said President and Chief Executive Officer of Encompass Health, Mark Tarr. “We are moving forward with our strategic initiatives positioning our Company to be the post-acute provider of choice with a proven record of delivering high-quality, cost-effective integrated care. We continue to see growth opportunities in both business segments as the demographic tailwind resulting from the aging of the population is driving increased demand for the services we provide.”

Based on its results for the first half of 2018 and its current expectations for the remainder of 2018, the Company is increasing its full-year guidance ranges for 2018.

	Full-Year 2018 Guidance Ranges
	Previous Guidance		Updated Guidance
	(In Millions, Except Per Share Data)
Net operating revenues	$4,110 to $4,210		$4,200 to $4,275
Adjusted EBITDA	$845 to $865		$865 to $880
Adjusted earnings per share from continuing operations attributable to Encompass Health	$3.30 to $3.45		$3.45 to $3.58

https://prn.to/2uPdLYI